SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-14-000110
Filing Date
2014-10-31
Accepted
2014-10-31 16:23:44
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-930201410q.htm 10-Q 1217294
2 VIKING AMENDMENT lgnd-vikingxamendmentno1to.htm EX-10.9 32433
3 CERTIFICATION lgnd-ex311_93014.htm EX-31.1 13653
4 CERTIFICATION lgnd-ex312_93014.htm EX-31.2 13584
5 CERTIFICATION lgnd-ex321_93014.htm EX-32.1 8487
6 CERTIFICATION lgnd-ex322_93014.htm EX-32.2 8317
  Complete submission text file 0000886163-14-000110.txt   10980400

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT lgnd-20140930.xml EX-101.INS 1888616
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20140930.xsd EX-101.SCH 56888
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20140930_cal.xml EX-101.CAL 89305
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20140930_def.xml EX-101.DEF 267846
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20140930_lab.xml EX-101.LAB 884602
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20140930_pre.xml EX-101.PRE 471231
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 141186869
SIC: 2834 Pharmaceutical Preparations